Tvardi TherapeuticsTVRD
13F holders, Q2 2026 (June 30)57holders −10
12new positions
20sold out
2famous investors
$1.91avg. 13F price*
At the end of Q2 2026, 57 institutions reported holding Tvardi Therapeutics Inc. (TVRD) in their 13F filings, down 10 from Q1 2026. 12 opened new positions and 20 sold out. The largest holders were Slate Path Capital LP ($1.3M), Vanguard Capital Management LLC ($654K) and American Financial Group Inc. ($425K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Cliff Asness (0.0% of AQR Capital Management's portfolio).
- Company
- Tvardi Therapeutics Inc.
- CUSIP
- 140755307
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $255K |
| Exits | 20 | $607K |
All 13F filers, Q1 2026 → Q2 2026: 219,509 shares bought and 693,992 shares sold, net −474,483 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 57 holders
| Slate Path Capital LP | 0.02% | No change | 704,118 | $1.3M |
| Vanguard Capital Management LLC | 0.00% | Reduce -0.1% | 344,382 | $654K |
| American Financial Group Inc. | 0.15% | No change | 223,659 | $425K |
| UBS Group AG | 0.00% | Add +120.3% | 111,133 | $211K |
| Silvercrest Asset Management Group LLC | 0.00% | No change | 101,034 | $192K |
| BlackRock, Inc. | 0.00% | Reduce -75.4% | 95,478 | $181K |
| Renaissance Technologies | 0.00% | Reduce -0.8% | 91,409 | $174K |
| Geode Capital Management, LLC | 0.00% | Reduce -50.5% | 90,350 | $172K |
| Morgan Stanley | 0.00% | Add +6.8% | 77,845 | $148K |
| Duncan Williams Asset Management, LLC | 0.03% | No change | 63,241 | $120K |
| Vanguard Fiduciary Trust Co. | 0.00% | Reduce -4.6% | 44,710 | $85K |
| Russell Investments Group, Ltd. | 0.00% | Add +85.5% | 43,228 | $82K |
| State Street Corp. | 0.00% | Reduce -65.1% | 33,900 | $64K |
| Susquehanna International Group, LLP | 0.00% | New | 33,165 | $63K |
| AQR Capital Management | 0.00% | Reduce -35.8% | 27,096 | $51K |
| Savant Capital, LLC | 0.00% | New | 19,462 | $49K |
| Northern Trust Corp. | 0.00% | Reduce -55.5% | 21,836 | $41K |
| Gsa Capital Partners LLP | 0.00% | New | 17,885 | $34K |
| Diadema Partners LP | 0.01% | New | 16,607 | $32K |
| XTX Topco Ltd | 0.00% | New | 14,868 | $28K |
| Brown Advisory Inc. | 0.00% | New | 11,200 | $21K |
| Arax Advisory Partners | 0.00% | Add +32.0% | 11,003 | $21K |
| Qube Research & Technologies Ltd | 0.00% | New | 10,210 | $19K |
| Persistent Asset Partners Ltd | 0.00% | New | 4,253 | $8K |
| PNC Financial Services Group, Inc. | 0.00% | Add +577.8% | 3,518 | $7K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 3,400 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -5.4% | 3,275 | $6K |
| FMR LLC | 0.00% | Reduce -75.5% | 1,293 | $2K |
| Wells Fargo & Company | 0.00% | Reduce -43.7% | 1,275 | $2K |
| Barclays PLC | 0.00% | Reduce -40.3% | 565 | $1K |
| Royal Bank of Canada | 0.00% | Add +448.2% | 466 | $1K |
| BNP Paribas Financial Markets | 0.00% | Reduce -83.2% | 239 | $454 |
| Group One Trading LLC | 0.00% | No change | 214 | $407 |
| Allworth Financial LP | 0.00% | Reduce -23.3% | 158 | $301 |
| TD Private Client Wealth LLC | 0.00% | New | 149 | $283 |
| JPMorgan Chase & Co. | 0.00% | Reduce -95.1% | 126 | $240 |
| Nisa Investment Advisors, LLC | 0.00% | New | 85 | $162 |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -31.3% | 46 | $88 |
| GAMMA Investing LLC | 0.00% | Reduce -55.1% | 40 | $76 |
| LRI Investments, LLC | 0.00% | No change | 27 | $51 |
| Osaic Holdings, Inc. | 0.00% | Add +1100.0% | 24 | $44 |
| Jones Financial Companies LLLP | 0.00% | Reduce -78.9% | 27 | $41 |
| Farther Finance Advisors, LLC | 0.00% | Reduce -30.4% | 16 | $30 |
| Harbour Investments, Inc. | 0.00% | No change | 15 | $29 |
| Leonteq Securities AG | 0.00% | No change | 12 | $23 |
| Rothschild Investment LLC | 0.00% | Reduce -25.0% | 9 | $17 |
| International Assets Investment Management, LLC | 0.00% | No change | 6 | $12 |
| IFP Advisors, Inc | 0.00% | Reduce -83.3% | 6 | $11 |
| Truvestments Capital LLC | 0.00% | No change | 4 | $8 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -40.0% | 3 | $6 |
| Larson Financial Group LLC | 0.00% | No change | 2 | $4 |
| True Wealth Design, LLC | 0.00% | Reduce -77.8% | 2 | $4 |
| Fifth Third Bancorp | 0.00% | No change | 1 | $2 |
| Citigroup Inc. | 0.00% | Reduce -99.6% | 1 | $2 |
| Axiom Investment Management LLC | 0.00% | New | 1 | $2 |
| Front Row Advisors LLC | 0.00% | New | 1 | $2 |
| SJS Investment Consulting Inc. | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is TVRD's weight in each manager's 13F, not the share of Tvardi Therapeutics Inc. the manager owns.